CVS Health Corp
CVS- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0000064803
No open-market purchases or sales by CVS Health Corp insiders were filed in the last 90 days; 2,074 institutions reported holding it in 13F filings for Q2 2026, worth $118.9B in total; 3 superinvestors hold it, including Viking Global Investors and Fairfax Financial.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CVS Health Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CVS Health Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Clark James David | SVP, Cont & Chief Acct Officer | 27,606 | Jun 29, 2026 | 3 |
| Compton-Phillips Amy | EVP, Chief Medical Officer | 9,557 | Jun 1, 2026 | 2 |
| Newman Brian | EVP, Chief Financial Officer | 3,008 | Jun 1, 2026 | 2 |
| Aguirre Fernando | Director | 10,513 | May 22, 2026 | 3 |
| Robbins Larry | Director | 4,824,799Indirect | May 21, 2026 | 3 |
| Brown C David II | Director | 129,316 | May 15, 2026 | 2 |
| Decoudreaux Alecia A | Director | – | May 15, 2026 | 2 |
| Kirby J Scott | Director | 14,434 | May 15, 2026 | 2 |
| Sansone Guy P | Director | 15,106 | May 15, 2026 | 2 |
| Gallina John E | Director | 582 | May 15, 2026 | 2 |
| Finucane Anne A. | Director | 591 | May 15, 2026 | 2 |
| Mahoney Michael F | Director | 6,345 | May 15, 2026 | 2 |
| Norwalk Leslie V | Director | 7,376 | May 15, 2026 | 2 |
| Shulman Douglas H. | Director | 5,929 | May 15, 2026 | 2 |
| Balser Jeffrey R. | Director | 15,717 | May 15, 2026 | 2 |
| Mandadi Tilak | EVP, Chief Exp & Tech Officer | 10,133 | May 11, 2026 | 3 |
| Nelson Steven H | EVP and President, Aetna | 2,900 | Apr 2, 2026 | 2 |
| Joyner J. David | President, CEO and Chair | 70,349 | Apr 2, 2026 | 2 |
| Khichi Samrat S. | EVP, CPO and General Counsel | 33,421 | Apr 2, 2026 | 2 |
| Capozzi Heidi B | EVP and Chief People Officer | 13,023 | Apr 2, 2026 | 3 |
| Shah Prem S | EVP and Group President | 64,356 | Apr 2, 2026 | 2 |
| Farah Roger N | Director | 19,438 | Dec 2, 2025 | 1 |
| Cowhey Thomas F. | EVP and CFO | 41,109 | Apr 3, 2025 | 0 |
| Deparle Nancy Ann | Director | 34,169 | Nov 25, 2024 | 0 |
| Millon Jean Pierre | Director | 4,514 | Nov 25, 2024 | 0 |
| Schapiro Mary L | Director | 7,585 | Nov 25, 2024 | 0 |
| Ludwig Edward J | Director | 21,630 | May 2, 2024 | 0 |
| Lynch Karen S | President and CEO | 74,687 | Apr 3, 2024 | 0 |
| Kane Brian A | EVP/President, Aetna | 12,569 | Apr 3, 2024 | 0 |
| Havanec Laurie P. | EVP and Chief People Officer | 9,426 | Apr 3, 2024 | 0 |
| Chaguturu Sreekanth K | EVP and Chief Medical Officer | 23,666 | Apr 3, 2024 | 0 |
| Guertin Shawn M | EVP & Chief Financial Officer | – | Apr 4, 2023 | 0 |
| Peluso Michelle A | EVP and Co-President of Retail | 124,383 | Apr 4, 2023 | 0 |
| Finke Daniel P | EVP/Pres, Health Care Benefits | 35,068 | Apr 4, 2023 | 0 |
| Moriarty Thomas M | EVP & General Counsel | 315,273 | Jan 4, 2023 | 0 |
| Weldon William C | Director | – | Nov 21, 2022 | 0 |
| Lotvin Alan | EVP&President-PharmacyServices | 109,183 | Aug 5, 2022 | 0 |
| Dorman David W | Director | 109,875 | May 13, 2022 | 0 |
| White Tony L | Director | 37,852 | May 13, 2022 | 0 |
| Brennan Troyen A | EVP and Chief Medical Officer | 232,676 | Apr 5, 2022 | 0 |
| Roberts Jonathan C | EVP & Chief Operating Officer | 426,025 | Apr 5, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 (view filing) | May 19-21 | 2 days | Robbins LarryDirector | SSale | −3.37M | $94.15 | −$317.5M | −41.1%4.82M after | 7 lots |
| May 21, 2026 (view filing) | May 21 | Same day | Robbins LarryDirector | SSale | −378.0K | $93.31 | −$35.3M | –0 after | Derivative |
| May 11, 2026 (view filing) | May 8 | 3 days | Mandadi TilakEVP, Chief Exp & Tech Officer | SSale | −69.6K | $89.58 | −$6.23M | −87.3%10.1K after | |
| Jan 27, 2026 (view filing) | Jan 23, 2025 | 369 daysLate | Nelson Steven HEVP and President, Aetna | PPurchaseCommon Stock (By Trust) | +24 | $53.70 | +$1.29K | New position24 after | |
| Oct 14, 2025 (view filing) | Sep 9-Oct 23, 2024 | 400 daysLate | Capozzi Heidi BEVP and Chief People Officer | PPurchase | +80 | $57.36 | +$4.59K | +1,600.0%85 after | 3 lots |
| Aug 29, 2025 (view filing) | Aug 20 | 9 daysLate | Finucane Anne A.Director | SSale | −7.50K | $71.02 | −$532.6K | −25.3%22.2K after | |
| Jun 9, 2025 (view filing) | Jun 5 | 4 days | Sansone Guy PDirector | PPurchase | +1.57K | $63.70 | +$100.0K | +15.0%12.0K after | |
| May 6, 2025 (view filing) | May 2-6 | 4 days | Robbins LarryDirector | SSale | −3.75M | $67.66 | −$253.7M | −31.4%8.20M after | 6 lots |
| Mar 7, 2025 (view filing) | Mar 5 | 2 days | Clark James DavidSVP, Cont & Chief Acct Officer | SSale | −7.51K | $66.35 | −$498.5K | −47.2%8.39K after | |
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | Mahoney Michael FDirector | PPurchaseCommon Stock (By Trust) | +30.0K | $66.70 | +$2.00M | +320.6%39.4K after | |
| May 2, 2024 (view filing) | May 2 | Same day | Ludwig Edward JDirector | PPurchase | +1.00K | $53.88 | +$53.9K | +4.8%21.6K after | |
| May 2, 2024 (view filing) | May 2 | Same day | Mahoney Michael FDirector | PPurchaseCommon Stock (By Trust) | +9.18K | $54.49 | +$500.3K | +5,246.3%9.36K after | |
| Feb 16, 2024 (view filing) | Feb 16 | Same day | Shah Prem SEVP and Pres-Pharm, Consumer W | SSale | −29.5K | $76.95 | −$2.27M | −42.6%39.8K after | |
| Nov 6, 2023 (view filing) | Nov 3 | 3 days | Ludwig Edward JDirector | PPurchase | +2.00K | $70.47 | +$140.9K | +10.7%20.6K after | |
| Aug 4, 2023 (view filing) | Aug 3 | 1 day | Clark James DavidSVP, Cont & Chief Acct Officer | SSale | −25.8K | $74.92 | −$1.93M | −84.6%4.70K after | 2 lots |
| May 5, 2023 (view filing) | May 3 | 2 days | Lynch Karen SPresident and CEO | PPurchaseCommon Stock (By Trust) | +14.0K | $69.75 | +$976.5K | +3.4%431.4K after | |
| Dec 16, 2022 (view filing) | Dec 15 | 1 day | Moriarty Thomas MEVP & General Counsel | SSale | −137.5K | $98.36 | −$13.5M | −18.4%608.1K after | 2 lots |
| Aug 5, 2022 (view filing) | Aug 3-4 | 2 days | Lotvin AlanEVP&President-PharmacyServices | SSale | −143.4K | $98.94 | −$14.2M | −56.8%109.2K after | 3 lots |
| Aug 5, 2022 (view filing) | Aug 3 | 2 days | Finke Daniel PEVP/Pres, Health Care Benefits | SSale | −9.55K | $100.00 | −$954.6K | −22.9%32.1K after | |
| Jun 30, 2022 (view filing) | Jun 28 | 2 days | Moriarty Thomas MEVP & General Counsel | SSale | −138.7K | $95.00 | −$13.2M | −18.1%626.3K after | 3 lots |
| Apr 12, 2022 (view filing) | Apr 8 | 4 days | Shah Prem SEVP and Co-President of Retail | SSale | −17.0K | $105.00 | −$1.78M | −28.1%43.5K after | 5 lots |
| Apr 6, 2022 (view filing) | Apr 4-5 | 2 days | Finke Daniel PEVP/Pres, Health Care Benefits | SSale | −61.3K | $100.12 | −$6.14M | −65.6%32.1K after | 4 lots |
| Mar 31, 2022 (view filing) | Mar 30 | 1 day | Shah Prem SEVP and Co-President of Retail | SSale | −5.35K | $104.70 | −$559.7K | −8.3%59.1K after | |
| Mar 18, 2022 (view filing) | Mar 17 | 1 day | Shah Prem SEVP and Co-President of Retail | SSale | −4.62K | $106.65 | −$493.1K | −7.3%59.1K after | 2 lots |
| Mar 17, 2022 (view filing) | Mar 15 | 2 days | Moriarty Thomas MEVP & General Counsel | SSale | −51.4K | $105.00 | −$5.39M | −5.8%836.8K after | |
| Feb 11, 2022 (view filing) | Feb 10 | 1 day | Ludwig Edward JDirector | PPurchase | +1.00K | $105.90 | +$105.9K | +5.8%18.3K after | |
| Feb 4, 2022 (view filing) | Feb 3 | 1 day | Brennan Troyen AEVP and Chief Medical Officer | SSale | −47.9K | $110.00 | −$5.27M | −25.7%138.2K after | |
| Feb 2, 2022 (view filing) | Feb 1 | 1 day | Lotvin AlanEVP&President-PharmacyServices | SSale | −21.4K | $106.50 | −$2.28M | −25.9%61.3K after | |
| Feb 1, 2022 (view filing) | Jan 28 | 4 days | Clark James DavidSVP, Cont & Chief Acct Officer | SSale | −6.06K | $109.00 | −$660.4K | −25.7%17.5K after | |
| Jan 28, 2022 (view filing) | Jan 27 | 1 day | Roberts Jonathan CEVP & Chief Operating Officer | SSale | −68.5K | $107.50 | −$7.36M | −39.0%107.1K after | |
| Nov 5, 2021 (view filing) | Nov 3 | 2 days | Roberts Jonathan CEVP & Chief Operating Officer | SSale | −108.9K | $95.00 | −$10.3M | −50.4%107.1K after | |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Brennan Troyen AEVP and Chief Medical Officer | SSale | −28.2K | $90.00 | −$2.53M | −16.9%138.2K after | |
| Oct 28, 2021 (view filing) | Oct 26 | 2 days | Brennan Troyen AEVP and Chief Medical Officer | SSale | −82.8K | $88.00 | −$7.28M | −37.4%138.2K after | 2 lots |
| Sep 7, 2021 (view filing) | Sep 2 | 5 days | Brennan Troyen AEVP and Chief Medical Officer | SSale | −2.63K | $87.00 | −$228.4K | −1.8%140.2K after | |
| Aug 5, 2021 (view filing) | Aug 5 | Same day | Ludwig Edward JDirector | PPurchase | +3.00K | $79.55 | +$238.7K | +20.9%17.3K after |